Medical News

RSS

DATATRAK International introduces next generation clinical trial management system

DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical® technologies and delivering related services for the clinical trials industry, today introduced the next generation clinical trial management system, UX CTMS 360.

15 Jun 2015

Genesis inks asset purchase agreement with Revera

Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that it has signed an asset purchase agreement with Revera Inc., a leading owner, operator and investor in the senior living sector, to acquire 24 of its skilled nursing facilities along with its contract rehabilitation business for $240 million.

15 Jun 2015

PTI to develop unique 3D game-based learning platform for pharma, biotech and medical device sectors

Pharmaceutical Training International, the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, has expanded its game-based learning platform into a fully customisable virtual learning environment.

From Pharmaceutical Training International 15 Jun 2015

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Juniper Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of therapeutics for women's health, announced today the first patient has been enrolled in a Phase II clinical trial of COL-1077, a 10% lidocaine bioadhesive gel that is intended as an acute-use anesthetic during minimally invasive gynecologic procedures.

15 Jun 2015

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

BIAL is presenting 11 research posters at the 19th International Congress of Parkinson's Disease and Movement Disorders (June 14–15, San Diego, CA). These evaluate the safety and efficacy of opicapone (BIA 9-1067), a novel once-daily catechol-O-methyltransferase (COMT) inhibitor for use as adjunctive therapy in levodopa-treated Parkinson’s disease patients with end of dose motor fluctuations.

15 Jun 2015

Novartis announces FDA approval of Promacta for treatment of children with chronic ITP

Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.

15 Jun 2015

Novasep announces launch of BioSC Lab for protein purification

Novasep, a leading supplier of manufacturing solutions to the life science industries, today announces the launch of BioSC Lab, the next-generation low pressure chromatography equipment for the biopharmaceutical industry.

15 Jun 2015

New study explores positive, negative aspects of parenting in mothers and fathers

Mothers’ and fathers’ parenting behaviour is more likely to resemble their own mothers’ than their fathers’, according to a new study.

15 Jun 2015

Vitamin D supplementation may treat Crohn’s disease

New research published in this month’s edition of United European Gastroenterology Journal suggests that supplementation with vitamin D may impact on the intestinal barrier dysfunction associated with Crohn’s disease, and could have a role in the treatment of the condition.

15 Jun 2015

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Ventana Medical Systems, Inc., a member of the Roche Group, today announced approval of the VENTANA ALK (D5F3) CDx Assay by the US Food and Drug Administration as a companion diagnostic to aid in the identification of patients for Pfizer's FDA approved targeted therapy, XALKORI (crizotinib).

15 Jun 2015

Poll: 60% of U.S. adults favor complete ban on powdered alcohol

After this year's legalization of powdered alcohol, some states have already banned it -- a move that the majority of the public supports, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

15 Jun 2015

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

Mesothelioma.us, an educational and authoritative website that offers free and in-depth resources for mesothelioma patients and their families, has just released a new case study that focuses on the experimental treatments for the disease.

15 Jun 2015

Merck KGaA, Darmstadt, Germany announces CE Mark certification for two innovative fertility technologies

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced that the two innovative fertility technologies Gavi and Geri have cleared a major milestone, achieving CE Mark certification.

15 Jun 2015

NTCELL Phase I/IIa clinical study meets primary endpoint in patients with Parkinson’s disease

Living Cell Technologies Limited today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson’s disease. The study, conducted in four patients in New Zealand, met its primary endpoint of safety, showing NTCELL implantation was well tolerated, with no adverse events considered to be related to NTCELL.

15 Jun 2015

Higher obstetric risk identified in ART pregnancies not linked to poorer academic performance in children

The academic performance of children conceived by assisted reproduction techniques (ART) is no better or worse than that of spontaneously conceived children when assessed at the ninth grade of their school education.

15 Jun 2015

Better way to predict survival in patients with HPV-positive oropharyngeal cancer

According to Sturgis, the incidence of HPV-positive oropharyngeal carcinoma has increased dramatically in recent years. Although patients with HPV-positive disease have a better prognosis than those with HPV-negative disease, researchers are still seeking a better understanding of what group of patients is more likely to respond to treatment.

15 Jun 2015

Study shows bacteriophages remain active against P. aeruginosa infection after nebulization

bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced new data demonstrating that bacteriophages remain active against Pseudomonas aeruginosa (P. aeruginosa) after nebulization.

15 Jun 2015

Study explores role of ALK1 protein in breast cancer metastasis

Pietras said that although prognosis for breast cancer is relatively good when detected in its early stages, metastatic disease is the cause of 90 percent of all cancer-related deaths. Therefore, learning more about the metastatic process and finding new cures to inhibit disease spread is at the center of clinical attention.

15 Jun 2015

Researchers examine proteins on surface of naive CD4+ T cells

The team headed by Dr. Kathrin Suttner, who, together with Prof. Dr. Carsten Schmidt-Weber, heads the airway immunology research group at the Helmholtz Zentrum München and Technische Universität München, concentrated its work on the so-called naive CD4+ T cells.

15 Jun 2015

Keele University academic calls for urgent review of cervical screening programmes

As Cervical Screening Awareness Week begins, a Keele University academic is calling for cervical screening programmes and perceptions of cervical cancer to be reviewed urgently, to encourage more older women to get regularly screened.

15 Jun 2015

Medical News

DATATRAK International introduces next generation clinical trial management system

Genesis inks asset purchase agreement with Revera

PTI to develop unique 3D game-based learning platform for pharma, biotech and medical device sectors

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Novartis announces FDA approval of Promacta for treatment of children with chronic ITP

Novasep announces launch of BioSC Lab for protein purification

New study explores positive, negative aspects of parenting in mothers and fathers

Vitamin D supplementation may treat Crohn’s disease

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Poll: 60% of U.S. adults favor complete ban on powdered alcohol

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

Merck KGaA, Darmstadt, Germany announces CE Mark certification for two innovative fertility technologies

NTCELL Phase I/IIa clinical study meets primary endpoint in patients with Parkinson’s disease

Higher obstetric risk identified in ART pregnancies not linked to poorer academic performance in children

Better way to predict survival in patients with HPV-positive oropharyngeal cancer

Study shows bacteriophages remain active against P. aeruginosa infection after nebulization

Study explores role of ALK1 protein in breast cancer metastasis

Researchers examine proteins on surface of naive CD4+ T cells

Keele University academic calls for urgent review of cervical screening programmes

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News